Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/42Z stock hub

FRA/42Z has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/42Zis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

25.6B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/42Z

In the news

Latest news · FRA/42Z

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-76.7

P25 n/aP50 n/aP75 n/a

ROIC-41.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/42Z market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

145

Groups with data

Currency

USD

Showing 145 of 145 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	883
Employees Change	319%
Employees Change Percent	65.1
Enterprise value	EUR 24.4B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 25.6B
Price	EUR 120
Price currency	EUR
Sic	2836
Symbol	fra/42Z
Website	https://www.revmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.64%
EV Earnings	-20.48x
EV/FCF	-26.21x
FCF yield	-3.63%
P/B ratio	19.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -976.2M
Net Income	EUR -1.2B
Profit Per Employee	EUR -1.3M
ROA	-37.53
Roa5y	-21.66
ROCE	-70.61
ROE	-76.67
Roe5y	-39.1
ROIC	-41.78

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	256.11%
Cagr3y	76.32%
Cagr5y	37.65%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 2B
Cash	EUR 1.7B
Current Assets	EUR 1.7B
Current Liabilities	EUR 245.6M
Debt	EUR 379.2M
Debt Equity	EUR 0.29
Debt FCF	EUR -0.41
Equity	EUR 1.3B
Interest Coverage	-38.07
Liabilities	EUR 653.8M
Long Term Assets	EUR 286M
Long Term Liabilities	EUR 408.2M
Net Cash	EUR 1.3B
Net Cash By Market Cap	EUR 4.98
Net Cash Growth	-25.28%
Net Debt Equity	EUR -0.98
Tangible Book Value	EUR 1.2B
Tangible Book Value Per Share	EUR 6.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.8
Net Working Capital	EUR -184.9M
Quick ratio	6.59
Working Capital	EUR 1.5B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.96%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	255.8%
200-day SMA	66.72
3Y total return	448.39%
50-day SMA	98.49
50-day SMA vs 200-day SMA	50over200
5Y total return	394.01%
All Time High	132
All Time High Change	-9.4%
All Time High Date	2026-04-20
All Time Low	13.8
All Time Low Change	766.3%
All Time Low Date	2022-05-12
ATR	4.41
Ch YTD	77.11
High	120.9
High52	132
High52 Date	2026-04-20
High52ch	-9.4%
Low	119.6
Low52	29.6
Low52 Date	2025-08-12
Low52ch	303.89%
Ma50ch	21.38%
Price vs 200-day SMA	79.18%
RSI	57.07
RSI Monthly	83.02
RSI Weekly	70.55
Sharpe ratio	1.9x
Sortino ratio	4.36
Total Return	-10.96%
Tr YTD	77.11
Tr1m	47.05%
Tr1w	-4.51%
Tr3m	48.51%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -1.2B

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	193,201,656%
Shares Insiders	2.22%
Shares Institutions	86.14%
Shares Qo Q	0.73%
Shares Yo Y	10.96%
Short Ratio	4.58

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -1.1B
Average Volume	237.05x
Bv Per Share	6.5
CAPEX	EUR -12.4M
Ch1m	47.05
Ch1w	-4.51
Ch1y	255.8
Ch3m	48.51
Ch3y	448.4
Ch5y	394
Ch6m	117.4
Change	-6.49%
Change From Open	-1.12
Close	127.9
Days Gap	-5.44
Depreciation Amortization	7,154,255.4
Dollar Volume	11,955
Earnings Date	2026-05-06
EBIT	EUR -1.2B
EBITDA	EUR -1.2B
EPS	EUR -6.18
F Score	1
FCF	EUR -929.5M
FCF EV Yield	-3.82x
Financing CF	745,352,416
Fiscal Year End	December
Founded	2,014
Goodwill	12,387,028.9
Investing CF	265,933,261
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Ma150	77.8
Ma150ch	53.67%
Ma20	120.6
Ma20ch	-0.89%
Net CF	94,141,079
Next Earnings Date	2026-08-06
Open	120.9
Position In Range	0
Ppne	136,835,627.9
Price Date	2026-05-08
Ptbv Ratio	20.66
Relative Volume	0.09x
Share Based Comp	156,637,849
Tr6m	117.36%
Volume	0

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/42Z pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/42Z stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/42Z?

Insider, institutional, and short-interest positioning.

Institutional ownership

+86.1%

Share of float held by funds and institutions

Insider ownership

+2.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/42Z momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.1

Neutral momentum band

Price vs 200-day MA

+79.2%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.90

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/42Z

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/42Z stock rating?

fra/42Z is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/42Z analysis?

The full report lives at /stocks/fra/42Z/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/42Z?

The latest report frames fra/42Z around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/42Z page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.